2023 Q1 Form 10-K Financial Statement
#000117184323001846 Filed on March 23, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $2.570M | $2.763M | $12.70M |
YoY Change | -33.96% | -24.53% | -8.84% |
Cost Of Revenue | $1.094M | $1.516M | $5.996M |
YoY Change | -36.05% | -3.23% | 4.32% |
Gross Profit | $1.477M | $1.246M | $6.702M |
YoY Change | -32.33% | -40.47% | -18.08% |
Gross Profit Margin | 57.45% | 45.11% | 52.78% |
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | $127.0K | $125.9K | $490.8K |
YoY Change | -3.57% | -2.84% | 2.53% |
% of Gross Profit | 8.6% | 10.1% | 7.32% |
Depreciation & Amortization | $24.46K | $32.55K | $135.4K |
YoY Change | -28.61% | -16.65% | -7.25% |
% of Gross Profit | 1.66% | 2.61% | 2.02% |
Operating Expenses | $127.0K | $600.7K | $490.8K |
YoY Change | -3.57% | -18.47% | 2.53% |
Operating Profit | $831.8K | $645.8K | $4.037M |
YoY Change | -44.69% | -52.42% | -28.76% |
Interest Expense | $120.3K | $198.5K | -$809.6K |
YoY Change | -134.08% | 329.03% | -483.96% |
% of Operating Profit | 14.47% | 30.74% | -20.05% |
Other Income/Expense, Net | $120.3K | -$809.6K | |
YoY Change | -134.08% | -483.97% | |
Pretax Income | $952.2K | $844.3K | $3.228M |
YoY Change | -17.26% | -39.84% | -45.09% |
Income Tax | $196.1K | $165.1K | $658.2K |
% Of Pretax Income | 20.59% | 19.55% | 20.39% |
Net Earnings | $756.1K | $679.2K | $2.570M |
YoY Change | -17.05% | -39.16% | -44.84% |
Net Earnings / Revenue | 29.42% | 24.58% | 20.23% |
Basic Earnings Per Share | $0.16 | $0.56 | |
Diluted Earnings Per Share | $0.16 | $0.15 | $0.56 |
COMMON SHARES | |||
Basic Shares Outstanding | 4.594M | 4.594M | 4.594M |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $6.972M | $6.484M | $6.484M |
YoY Change | -10.57% | -20.6% | -20.6% |
Cash & Equivalents | $1.202M | $830.5K | $830.5K |
Short-Term Investments | $5.770M | $5.654M | $5.654M |
Other Short-Term Assets | $319.5K | $387.1K | $387.1K |
YoY Change | -31.67% | 100.99% | 100.99% |
Inventory | $2.470M | $1.672M | $1.672M |
Prepaid Expenses | |||
Receivables | $1.481M | $1.428M | $1.428M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $11.24M | $9.971M | $9.971M |
YoY Change | -8.69% | -13.92% | -13.92% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $537.3K | $559.2K | $559.2K |
YoY Change | -14.64% | -15.13% | -15.13% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $161.1K | $110.5K | $110.5K |
YoY Change | |||
Total Long-Term Assets | $698.4K | $669.7K | $669.7K |
YoY Change | 10.95% | 1.65% | 1.65% |
TOTAL ASSETS | |||
Total Short-Term Assets | $11.24M | $9.971M | $9.971M |
Total Long-Term Assets | $698.4K | $669.7K | $669.7K |
Total Assets | $11.94M | $10.64M | $10.64M |
YoY Change | -7.73% | -13.09% | -13.09% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $441.5K | $30.42K | $30.42K |
YoY Change | 20.04% | -92.6% | -92.6% |
Accrued Expenses | $1.314M | $1.322M | $1.322M |
YoY Change | -14.31% | -18.76% | -18.76% |
Deferred Revenue | $140.8K | $0.00 | |
YoY Change | 59.01% | -100.0% | |
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $1.918M | $1.374M | $1.374M |
YoY Change | -4.62% | -41.24% | -41.24% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.918M | $1.374M | $1.374M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $1.918M | $1.374M | $1.374M |
YoY Change | -13.17% | -43.26% | -43.26% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $9.563M | $8.807M | |
YoY Change | -6.91% | -5.92% | |
Common Stock | $459.4K | $459.4K | |
YoY Change | 0.0% | 0.0% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $10.02M | $9.267M | $9.267M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $11.94M | $10.64M | $10.64M |
YoY Change | -7.73% | -13.09% | -13.09% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $756.1K | $679.2K | $2.570M |
YoY Change | -17.05% | -39.16% | -44.84% |
Depreciation, Depletion And Amortization | $24.46K | $32.55K | $135.4K |
YoY Change | -28.61% | -16.65% | -7.25% |
Cash From Operating Activities | $417.6K | $624.7K | $2.525M |
YoY Change | 1423.21% | -62.47% | -52.47% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $2.582K | $15.01K | $75.18K |
YoY Change | -46.65% | -143.66% | -35.4% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$43.51K | $1.148M | $972.7K |
YoY Change | 2.88% | -3.87% | -1549.69% |
Cash From Investing Activities | -$46.09K | $1.133M | $897.6K |
YoY Change | -2.21% | -2.32% | -589.2% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | $0.00 | $3.123M | |
YoY Change | -39.82% | ||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $0.00 | -1.424M | -$3.123M |
YoY Change | -52.3% | -39.82% | |
NET CHANGE | |||
Cash From Operating Activities | $417.6K | 624.7K | $2.525M |
Cash From Investing Activities | -$46.09K | 1.133M | $897.6K |
Cash From Financing Activities | $0.00 | -1.424M | -$3.123M |
Net Change In Cash | $371.5K | 333.9K | $299.2K |
YoY Change | -1984.55% | -307.79% | -596.82% |
FREE CASH FLOW | |||
Cash From Operating Activities | $417.6K | $624.7K | $2.525M |
Capital Expenditures | $2.582K | $15.01K | $75.18K |
Free Cash Flow | $415.0K | $609.7K | $2.450M |
YoY Change | 1738.35% | -64.11% | -52.86% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
20063 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
20252 | usd |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.10 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.10 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
10000000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4594319 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4594319 | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4594319 | |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4594319 | |
CY2022 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | usd |
CY2022 | ug |
Number Of Vendors
NumberOfVendors
|
6 | pure |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | usd |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | usd |
CY2021 | ug |
Defined Contribution Plan Employer Discretionary Contribution Amount Per Year Authorized
DefinedContributionPlanEmployerDiscretionaryContributionAmountPerYearAuthorized
|
109000 | usd |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
1-10526 | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
11-1719724 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
230 Marcus Blvd. | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Hauppauge | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
11788 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
631 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
273-0900 | |
CY2022 | dei |
Security12b Title
Security12bTitle
|
Common Stock, $.10 par value | |
CY2022 | dei |
Trading Symbol
TradingSymbol
|
UG | |
CY2022 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
68868800 | usd |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
4594319 | |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
23 | |
CY2022 | dei |
Auditor Name
AuditorName
|
Baker Tilly US, LLP | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Uniondale, NY | |
CY2022 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
12698503 | usd |
CY2021 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
13929629 | usd |
CY2022 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
5996376 | usd |
CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
5747931 | usd |
CY2022 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
2174127 | usd |
CY2021 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
2035970 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
490770 | usd |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
478642 | usd |
CY2022 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
8661273 | usd |
CY2021 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
8262543 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
4037230 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5667086 | usd |
CY2022 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
236695 | usd |
CY2021 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
233857 | usd |
CY2022 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
-1046245 | usd |
CY2021 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
-23018 | usd |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-809550 | usd |
CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
210839 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
3227680 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
5877925 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
658168 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1219383 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2569512 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4658542 | usd |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.56 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
1.01 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4594319 | |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4594319 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
830452 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
531213 | usd |
CY2022Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
5653516 | usd |
CY2021Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
7635463 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1427576 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1813346 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
1672012 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
1410789 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
201846 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
192579 | usd |
CY2022Q4 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
185228 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
9970630 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
11583390 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
110544 | usd |
CY2022Q4 | us-gaap |
Land
Land
|
69000 | usd |
CY2021Q4 | us-gaap |
Land
Land
|
69000 | usd |
CY2022Q4 | us-gaap |
Fixtures And Equipment Gross
FixturesAndEquipmentGross
|
4585055 | usd |
CY2021Q4 | us-gaap |
Fixtures And Equipment Gross
FixturesAndEquipmentGross
|
4605742 | usd |
CY2022Q4 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
2895742 | usd |
CY2021Q4 | us-gaap |
Buildings And Improvements Gross
BuildingsAndImprovementsGross
|
2853718 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7549797 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7528460 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6990636 | usd |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
6869598 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
559161 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
658862 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
10640335 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
12242252 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
30415 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
410894 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1322056 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1627390 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
190164 | usd |
CY2021Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
88738 | usd |
CY2022Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
21220 | usd |
CY2021Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
20575 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1373691 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2337761 | usd |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
83222 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
459432 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
459432 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
8807212 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
9361837 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9266644 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9821269 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
10640335 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
12242252 | usd |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10354307 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4658542 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9821269 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2569512 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9266644 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2569512 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
4658542 | usd |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
135396 | usd |
CY2021 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
145977 | usd |
CY2022 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-2445 | usd |
CY2021 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
14799 | usd |
CY2022 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
-1046245 | usd |
CY2021 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
-23018 | usd |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-189 | usd |
CY2021 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
6235 | usd |
CY2022 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
29000 | usd |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-193766 | usd |
CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-68462 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-385959 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
431883 | usd |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
290223 | usd |
CY2021 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-4984 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
9267 | usd |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
31371 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
|
185228 | usd |
CY2021 | us-gaap |
Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
|
-99107 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-380479 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
379094 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-305334 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
263933 | usd |
CY2022 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-190164 | usd |
CY2021 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
190164 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-88738 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
88738 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
2525169 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
5313277 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
75179 | usd |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
116375 | usd |
CY2022 | us-gaap |
Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
|
37039 | usd |
CY2022 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
1931969 | usd |
CY2021 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
4219760 | usd |
CY2022 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
2867671 | usd |
CY2021 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
4152660 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
897562 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-183475 | usd |
CY2022 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
3123492 | usd |
CY2021 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
5190033 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3123492 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-5190033 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
299239 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-60231 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
531213 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
591444 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
830452 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
531213 | usd |
CY2022 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1125000 | usd |
CY2021 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1100000 | usd |
CY2022Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
645 | usd |
CY2021Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
1547 | usd |
CY2021 | ug |
Tradein Received From Sale Of Asset
TradeinReceivedFromSaleOfAsset
|
29000 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><span style="text-decoration: underline; ">Use of Estimates</span></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In preparing financial statements in conformity with a Generally Accepted Accounting Principles in the United States of America (“US GAAP”), management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates. Such estimated items include the allowance for bad debts, reserve for inventory obsolescence, accrued distribution fees, outdated material returns, possible impairment of marketable securities and the allocation of overhead.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"/> | |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
20063 | usd |
CY2021Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
20252 | usd |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
190164 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
0 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
12698503 | usd |
CY2021 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
13929629 | usd |
CY2021Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
|
7466168 | usd |
CY2021Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
|
7635463 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
12698503 | usd |
CY2021 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
13929629 | usd |
CY2022Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
105000 | usd |
CY2022Q2 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.37 | |
CY2022Q4 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.31 | |
CY2022 | us-gaap |
Dividends
Dividends
|
3124137 | usd |
CY2022 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
3123492 | usd |
CY2022Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
645 | usd |
CY2021Q2 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.48 | |
CY2021Q4 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.65 | |
CY2021 | us-gaap |
Dividends
Dividends
|
5191580 | usd |
CY2021 | us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
5190033 | usd |
CY2021Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
1547 | usd |
CY2021Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
|
169295 | usd |
CY2022 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
2867671 | usd |
CY2021 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | usd |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><span style="text-decoration: underline; ">Concentration of Credit Risk</span></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Accounts receivable potentially exposes the Company to concentrations of credit risk. The Company monitors the amount of credit it allows each of its customers, using the customer’s prior payment history to determine how much credit to allow or whether any credit should be given at all. It is the Company’s policy to discontinue shipments to any customer that is substantially past due on its payments. The Company sometimes requires payment in advance from customers whose payment record is questionable. As a result of its monitoring of the outstanding credit allowed for each customer, as well as the fact that the majority of the Company’s sales are to customers whose satisfactory credit and payment record has been established over a long period of time, the Company believes that its accounts receivable credit risk has been reduced.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For the year ended <em style="font: inherit;"> December 31, 2022, </em><span style="-sec-ix-hidden:c95656233">four</span> of the Company’s pharmaceutical wholesalers and cosmetic ingredient distributors accounted for approximately 72% of the Company’s gross sales during the year and approximately 81% of its outstanding accounts receivable at <em style="font: inherit;"> December 31, 2022. </em>For the year ended <em style="font: inherit;"> December 31, 2021, </em>the same four pharmaceutical wholesalers and cosmetic ingredient distributors accounted for a total of approximately 75% of the Company’s gross sales during the year and 80% of its outstanding accounts receivable at <em style="font: inherit;"> December 31, 2021.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"/> | |
CY2021 | ug |
Number Of Vendors
NumberOfVendors
|
6 | pure |
CY2022 | us-gaap |
Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
|
-364074 | usd |
CY2021 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
4152660 | usd |
CY2021 | us-gaap |
Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
|
111917 | usd |
CY2022 | us-gaap |
Advertising Expense
AdvertisingExpense
|
19000 | usd |
CY2021 | us-gaap |
Advertising Expense
AdvertisingExpense
|
31000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
437775 | usd |
CY2022Q4 | ug |
Deferred Tax Liabilities Accounts Receivable
DeferredTaxLiabilitiesAccountsReceivable
|
304004 | usd |
CY2021Q4 | ug |
Deferred Tax Liabilities Accounts Receivable
DeferredTaxLiabilitiesAccountsReceivable
|
385056 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
830452 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
531213 | usd |
CY2022 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
-1046245 | usd |
CY2021 | us-gaap |
Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
|
-23018 | usd |
CY2022 | us-gaap |
Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
|
-364074 | usd |
CY2021 | us-gaap |
Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
|
111917 | usd |
CY2022 | us-gaap |
Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
|
-682171 | usd |
CY2021 | us-gaap |
Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
|
-134935 | usd |
CY2022Q4 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
6166392 | usd |
CY2022Q4 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
5653516 | usd |
CY2022Q4 | ug |
Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
|
-512876 | usd |
CY2022Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
|
6166392 | usd |
CY2022Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
|
5653516 | usd |
CY2022Q4 | ug |
Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
|
-512876 | usd |
CY2021Q4 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
7466168 | usd |
CY2021Q4 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
7635463 | usd |
CY2021Q4 | ug |
Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
|
169295 | usd |
CY2022Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
601125 | usd |
CY2021Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
494348 | usd |
CY2022Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
16520 | usd |
CY2021Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
119069 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
1054367 | usd |
CY2021Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
797372 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
1672012 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
1410789 | usd |
CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
64000 | usd |
CY2021Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
35000 | usd |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
850344 | usd |
CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
1287749 | usd |
CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1590 | usd |
CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
96 | usd |
CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
851934 | usd |
CY2021 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
1287845 | usd |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-193766 | usd |
CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-68462 | usd |
CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-193766 | usd |
CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-68462 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
658168 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1219383 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
42446 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
|
38918 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
44812 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
61471 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
|
35552 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
677813 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
1234364 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
1256 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
76 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
|
10000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
|
0.003 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
|
10000 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
|
0.002 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
|
6300 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
|
0.002 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
|
2923 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
|
0.001 | pure |
CY2022 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-4601 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.001 | pure |
CY2021 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-2134 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
658168 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.204 | pure |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1219383 | usd |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.207 | pure |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
4213 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
|
4253 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
13440 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
|
7350 | usd |
CY2022Q4 | ug |
Deferred Tax Assets Accounts Payable
DeferredTaxAssetsAccountsPayable
|
6367 | usd |
CY2021Q4 | ug |
Deferred Tax Assets Accounts Payable
DeferredTaxAssetsAccountsPayable
|
86288 | usd |
CY2022Q4 | ug |
Deferred Tax Assets Capitalized Research And Development
DeferredTaxAssetsCapitalizedResearchAndDevelopment
|
92756 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
|
107704 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
277326 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
339884 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
501806 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
391262 | usd |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
520997 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
110544 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
83222 | usd |
CY2022 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
81000 | usd |
CY2021 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
80000 | usd |
CY2022 | ug |
Defined Contribution Plan Employer Discretionary Contribution Amount Per Year Authorized
DefinedContributionPlanEmployerDiscretionaryContributionAmountPerYearAuthorized
|
109000 | usd |
CY2022 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | pure |
CY2022 | ug |
Revenue From Contract With Customer Including Assessed Tax Gross
RevenueFromContractWithCustomerIncludingAssessedTaxGross
|
13905962 | usd |
CY2021 | ug |
Revenue From Contract With Customer Including Assessed Tax Gross
RevenueFromContractWithCustomerIncludingAssessedTaxGross
|
14947167 | usd |
CY2022 | ug |
Sales Returns And Allowances
SalesReturnsAndAllowances
|
1207459 | usd |
CY2021 | ug |
Sales Returns And Allowances
SalesReturnsAndAllowances
|
1017538 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
12698503 | usd |
CY2021 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
13929629 | usd |
CY2022 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
12698503 | usd |
CY2021 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
13929629 | usd |
CY2022 | ug |
Revenue From Contract With Customer Including Assessed Tax Gross
RevenueFromContractWithCustomerIncludingAssessedTaxGross
|
13905962 | usd |
CY2021 | ug |
Revenue From Contract With Customer Including Assessed Tax Gross
RevenueFromContractWithCustomerIncludingAssessedTaxGross
|
14947167 | usd |
CY2022Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
175496 | usd |
CY2021Q4 | us-gaap |
Accrued Bonuses Current
AccruedBonusesCurrent
|
348000 | usd |
CY2022Q4 | ug |
Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
|
395536 | usd |
CY2021Q4 | ug |
Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
|
359550 | usd |
CY2022Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
53475 | usd |
CY2021Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
292560 | usd |
CY2022Q4 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
|
94326 | usd |
CY2021Q4 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
|
109000 | usd |
CY2022Q4 | ug |
Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
|
68349 | usd |
CY2021Q4 | ug |
Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
|
64038 | usd |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
66500 | usd |
CY2021Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
61500 | usd |
CY2022Q4 | ug |
Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
|
369154 | usd |
CY2021Q4 | ug |
Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
|
313904 | usd |
CY2022Q4 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
80926 | usd |
CY2021Q4 | us-gaap |
Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
|
56857 | usd |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
18294 | usd |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
21981 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1322056 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1627390 | usd |
CY2022Q4 | ug |
Convertible Common Stock Shares Issuable Upon Conversion
ConvertibleCommonStockSharesIssuableUponConversion
|
447 | |
CY2022 | ug |
Payments For Accrued Dividends On Unconverted Shares
PaymentsForAccruedDividendsOnUnconvertedShares
|
447 | usd |